Dr. R. Holm
Janssen Pharmaceutica N. V., Belgium

Position

Head and Scientific Director, Liquids & Parenterals at Janssen Pharmaceutica N. V

Background

Having completed his MSc. Pharm. degree at the Royal Danish School of Pharmacy, now part of the university of Copenhagen, he proceeded with a PhD at the same institution. After the PhD, moved to work for the pharmaceutical industry, but have maintained a substantial link into the academical world and have published more than 100 peer review articles. Given the industrial position Dr. Holm have a very broad scientific interest, but in particular bio pharmacy and formulation of low soluble drugs constitutes the majority of initiated research cooperation. Before joining Janssen, Dr. Holm worked as senior director for pharmaceutical science and CMC biologics at Lundbeck.

Role in PEARRL

Main Supervisor ESR 14, Co-Supervisor ESR 1, ESR 2, ESR 9 and ESR 11

Key Publications

• Olesen, N. E., Westh, P., & Holm, R. (2016). A heuristic model to quantify the impact of excess cyclodextrin on oral drug absorption from aqueous solution. European Journal of Pharmaceutics and Biopharmaceutics, 102, 142-151.
• Knopp, M. M., Gannon, N., Porsch, I., Rask, M. B., Olesen, N. E., Langguth, P., Holm, R., ... & Rades, T. (2016). A Promising New Method to Estimate Drug-Polymer Solubility at Room Temperature. Journal of Pharmaceutical Sciences.
• Doreth, M., Löbmann, K., Grohganz, H., Holm, R., de Diego, H. L., Rades, T., & Priemel, P. A. (2016). Glass solution formation in water-In situ amorphization of naproxen and ibuprofen with Eudragit® E PO. Journal of Drug Delivery Science and Technology.